HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Memon, S. A. Articles by Zacharchuk, C. M. Search for Related Content PubMed PubMed Citation Articles by Memon, S. A. Articles by Zacharchuk, C. M.

Cutting Edge: Apoptosis Induced by a Chimeric Fas/FLICE Receptor: Lack of Requirement for Fas- or FADD-Binding Proteins

Laboratory of Immune Cell Biology, Division of Basic Sciences, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892

Current models for Fas (CD95)-mediated apoptosis suggest that FLICE/caspase-8 is recruited and activated, which results in cell death. However, the role of additional molecules in Fas signaling and FLICE activation is not clear. A chimeric Fas/FLICE (F/F) receptor, containing the extracellular/transmembrane portion of Fas and the caspase region of FLICE, mediated anti-Fas apoptosis. FLICE protease subunits were generated from the F/F precursor. Killing induced by Fas, but not F/F, was blocked by a dominant negative FADD. Apoptosis triggered through Fas and F/F was inhibited by coexpression of CrmA and p35, but not Bcl-xL. F/F bypassed Fas resistance in COS-7 cells and blocking by the death effector domain (DED)-containing viral protein MC159. These results show that: 1) F/F induces cell death, indicating that FLICE activation is sufficient for apoptosis and does not require additional Fas- or FADD-binding proteins; and 2) F/F bypasses proximal defects in Fas signaling that prevent FLICE recruitment or activation.

This article has been cited by other articles:

				D. Delmas, C. Rebe, S. Lacour, R. Filomenko, A. Athias, P. Gambert, M. Cherkaoui-Malki, B. Jannin, L. Dubrez-Daloz, N. Latruffe, et al. Resveratrol-induced Apoptosis Is Associated with Fas Redistribution in the Rafts and the Formation of a Death-inducing Signaling Complex in Colon Cancer Cells J. Biol. Chem., October 17, 2003; 278(42): 41482 - 41490. [Abstract] [Full Text] [PDF]

				L. Cartee, S. C. Maggio, R. Smith, H. M. Sankala, P. Dent, and S. Grant Protein Kinase C-dependent Activation of the Tumor Necrosis Factor Receptor-mediated Extrinsic Cell Death Pathway Underlies Enhanced Apoptosis in Human Myeloid Leukemia Cells Exposed to Bryostatin 1 and Flavopiridol Mol. Cancer Ther., January 1, 2003; 2(1): 83 - 93. [Abstract] [Full Text] [PDF]

				L. Cartee, R. Smith, Y. Dai, M. Rahmani, R. Rosato, J. Almenara, P. Dent, and S. Grant Synergistic Induction of Apoptosis in Human Myeloid Leukemia Cells by Phorbol 12-Myristate 13-Acetate and Flavopiridol Proceeds via Activation of Both the Intrinsic and Tumor Necrosis Factor-Mediated Extrinsic Cell Death Pathways Mol. Pharmacol., June 1, 2002; 61(6): 1313 - 1321. [Abstract] [Full Text] [PDF]

				T. P. Quinn, S. J. Soifer, K. Ramer, L. T. Williams, and M. C. Nakamura A Receptor for Vascular Endothelial Growth Factor That Stimulates Endothelial Apoptosis Cancer Res., December 1, 2001; 61(24): 8629 - 8637. [Abstract] [Full Text] [PDF]

				D. G. Stupack, X. S. Puente, S. Boutsaboualoy, C. M. Storgard, and D. A. Cheresh Apoptosis of adherent cells by recruitment of caspase-8 to unligated integrins J. Cell Biol., October 29, 2001; 155(3): 459 - 470. [Abstract] [Full Text] [PDF]

				I. M. Catlett, P. Xie, B. S. Hostager, and G. A. Bishop Signaling Through MHC Class II Molecules Blocks CD95-Induced Apoptosis J. Immunol., May 15, 2001; 166(10): 6019 - 6024. [Abstract] [Full Text] [PDF]

				A. D. Badley, A. A. Pilon, A. Landay, and D. H. Lynch Mechanisms of HIV-associated lymphocyte apoptosis Blood, November 1, 2000; 96(9): 2951 - 2964. [Abstract] [Full Text] [PDF]

				P. Juo, M. Sue-Ann Woo, C. J. Kuo, P. Signorelli, H. P. Biemann, Y. A. Hannun, and J. Blenis FADD Is Required for Multiple Signaling Events Downstream of the Receptor Fas Cell Growth Differ., December 1, 1999; 10(12): 797 - 804. [Abstract] [Full Text]

				I. M. Catlett and G. A. Bishop Cutting Edge: A Novel Mechanism for Rescue of B Cells from CD95/Fas-Mediated Apoptosis J. Immunol., September 1, 1999; 163(5): 2378 - 2381. [Abstract] [Full Text] [PDF]

				O. Micheau, E. Solary, A. Hammann, and M.-T. Dimanche-Boitrel Fas Ligand-independent, FADD-mediated Activation of the Fas Death Pathway by Anticancer Drugs J. Biol. Chem., March 19, 1999; 274(12): 7987 - 7992. [Abstract] [Full Text] [PDF]

				H. Y. Chang, X. Yang, and D. Baltimore Dissecting Fas signaling with an altered-specificity death-domain mutant: Requirement of FADD binding for apoptosis but not Jun N-terminal kinase activation PNAS, February 16, 1999; 96(4): 1252 - 1256. [Abstract] [Full Text] [PDF]

				M. S. Hu, J. D. Schwartzman, G. R. Yeaman, J. Collins, R. Seguin, I. A. Khan, and L. H. Kasper Fas-FasL Interaction Involved in Pathogenesis of Ocular Toxoplasmosis in Mice Infect. Immun., February 1, 1999; 67(2): 928 - 935. [Abstract] [Full Text] [PDF]